Schering Albuterol Recall Linked With 24 Fatalities, Public Citizen Asserts
Executive Summary
Schering-Plough's testing of albuterol inhalers returned to the company shows that in every case where an injury is alleged to have occurred because of a faulty inhaler, the canister contained active ingredient, the company maintains.
You may also be interested in...
Schering GMP Criminal Investigation Continues After Consent Decree
Schering-Plough faces a potential criminal case regarding GMP violations after finalizing a consent agreement with FDA May 17
Schering-Plough Claritin DTC Ads Are Target Of Rx Consumer Litigation Group
A consumer litigation coalition lawsuit against Schering-Plough over direct-to-consumer advertising for Claritin (loratadine) is claiming that the company's DTC ads are misleading because they imply a higher degree of efficacy for the allergy drug than has been proven.
Schering-Plough Claritin DTC Ads Are Target Of Rx Consumer Litigation Group
A consumer litigation coalition lawsuit against Schering-Plough over direct-to-consumer advertising for Claritin (loratadine) is claiming that the company's DTC ads are misleading because they imply a higher degree of efficacy for the allergy drug than has been proven.